UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 226

Sortiert nach

The ying and yang of idebenone: Not too little, not too much – cell death in NQO1 deficient cells and the mouse retina

Free radical biology & medicine, 2020-05, Vol.152, p.551-560

2020

Volltextzugriff (PDF)

The effect of metformin on apoptosis in a breast cancer presurgical trial

British journal of cancer, 2013-11, Vol.109 (11), p.2792-2797

2013

Volltextzugriff (PDF)

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

British journal of cancer, 2013-04, Vol.108 (8), p.1593-1601

2013

Volltextzugriff (PDF)

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Annals of oncology, 2013-07, Vol.24 (7), p.1859-1866

2013

Volltextzugriff (PDF)

Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1147-1151

2001

Volltextzugriff (PDF)

Chemical profile and cytotoxic evaluation of aerial parts of Euphorbia tirucalli L. on gastric adenocarcinoma (AGS cells)

Natural product research, 2023-12, Vol.37 (24), p.1-4273

2023

Volltextzugriff (PDF)

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

Annals of oncology, 2013-11, Vol.24 (11), p.2753-2760

2013

Volltextzugriff (PDF)

Assessment of the Quality of Life of Vulnerable Young Males with Severe Emotional and Behaviour Difficulties in a Residential Setting

TheScientificWorld, 2013-01, Vol.2013 (1), p.357341-357341

2013

Volltextzugriff (PDF)

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

Annals of oncology, 2010-05, Vol.21 (5), p.949-954

2010

Volltextzugriff (PDF)

PO37 HPR: a randomized chemoprevention trial in high risk women

Breast (Edinburgh), 2014-11, Vol.23, p.S14-S14

2014

Volltextzugriff (PDF)

NMNAT2 is a druggable target to drive neuronal NAD production

Nature communications, 2024-07, Vol.15 (1), p.6256-15, Article 6256

2024

Volltextzugriff (PDF)

Development of neuroprotective small molecular drugs targeting NMNAT2

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, Vol.64 (8)

2023

Volltextzugriff (PDF)

The Need for and Characteristics of Randomized, Phase III Trials to Evaluate Symptom Management in Patients With Cancer

JNCI : Journal of the National Cancer Institute, 2002-08, Vol.94 (16), p.1184-1185

2002

Volltextzugriff (PDF)

Abstract P4-15-06: Low dose tamoxifen lowers recurrences after mastectomy for in situ neoplasia. Ten-year results of a monoinstitutional study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-15-06

2018

Volltextzugriff (PDF)

Effects of prolonged autovehicle driving on male reproductive function: A study among taxi drivers

American journal of industrial medicine, 1996-12, Vol.30 (6), p.750-758

1996

Volltextzugriff (PDF)

Assessing the Clinical Significance of Single Items Relative to Summated Scores

Mayo Clinic proceedings, 2002-05, Vol.77 (5), p.479-487

2002

Volltextzugriff (PDF)

NMNAT2 is a druggable target for neuroprotection in glaucoma

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, Vol.64 (8)

2023

Volltextzugriff (PDF)

Targeting NMNAT2 for neuroprotection in glaucoma

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, Vol.63 (7)

2022

Volltextzugriff (PDF)

Measurement issues in quality-of-life assessments

Oncology nursing forum, 2006-01, Vol.33 (1 Suppl), p.13

Varricchio, Claudette G

2006

Volltextzugriff (PDF)

Funding ideas for new research

Cancer, 2001-09, Vol.92 (S6), p.1737-1743

2001

Volltextzugriff (PDF)

Research issues in cancer survivorship: report of a workshop sponsored by the Office of Cancer Survivorship, National Cancer Institute

Cancer epidemiology, biomarkers & prevention, 1998-12, Vol.7 (12), p.1145-1151

1998

Volltextzugriff (PDF)

Abstract PD04-07: The Ki-67 labeling index predicts the risk of recurrence of DIN patients treated with radiotherapy following breast conserving surgery

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD04-07-PD04-07

2012

Volltextzugriff (PDF)

Prognostic Value of KI-67 Labeling Index in Patients with Ductal Intraepithelial Neoplasia of the Breast. Postsurgical Outcome for 1171 Women Cared for in One Single Institution Over 10 Years

Annals of oncology, 2012-09, Vol.23, p.ix83

2012

Volltextzugriff (PDF)

Clinical trials referral resource. Health-Related quality of life in cancer prevention clinical trials

Oncology (Williston Park, N.Y.), 2001-11, Vol.15 (11), p.1455, 1458-1455

2001

Volltextzugriff (PDF)

Safety and efficacy of HRT and low-dose tamoxifen in a phase II trial (HOT): Analysis of mammographic density and endometrial thickness

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1527-1527

2011

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(195)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The ying and yang of idebenone: Not too little, not too much – cell death in NQO1 deficient cells and the mouse retina

The effect of metformin on apoptosis in a breast cancer presurgical trial

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base

Chemical profile and cytotoxic evaluation of aerial parts of Euphorbia tirucalli L. on gastric adenocarcinoma (AGS cells)

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

Assessment of the Quality of Life of Vulnerable Young Males with Severe Emotional and Behaviour Difficulties in a Residential Setting

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

PO37 HPR: a randomized chemoprevention trial in high risk women

NMNAT2 is a druggable target to drive neuronal NAD production

Development of neuroprotective small molecular drugs targeting NMNAT2

The Need for and Characteristics of Randomized, Phase III Trials to Evaluate Symptom Management in Patients With Cancer

Abstract P4-15-06: Low dose tamoxifen lowers recurrences after mastectomy for in situ neoplasia. Ten-year results of a monoinstitutional study

Effects of prolonged autovehicle driving on male reproductive function: A study among taxi drivers

Assessing the Clinical Significance of Single Items Relative to Summated Scores

NMNAT2 is a druggable target for neuroprotection in glaucoma

Targeting NMNAT2 for neuroprotection in glaucoma

Measurement issues in quality-of-life assessments

Funding ideas for new research

Research issues in cancer survivorship: report of a workshop sponsored by the Office of Cancer Survivorship, National Cancer Institute

Abstract PD04-07: The Ki-67 labeling index predicts the risk of recurrence of DIN patients treated with radiotherapy following breast conserving surgery

Prognostic Value of KI-67 Labeling Index in Patients with Ductal Intraepithelial Neoplasia of the Breast. Postsurgical Outcome for 1171 Women Cared for in One Single Institution Over 10 Years

Clinical trials referral resource. Health-Related quality of life in cancer prevention clinical trials

Safety and efficacy of HRT and low-dose tamoxifen in a phase II trial (HOT): Analysis of mammographic density and endometrial thickness

Suchergebnisse filtern